Get started
Author

Carsten Boesler

Observed names: Boesler, Carsten, C. Boesler, Carsten Boesler (20103688)
ORCID: 0009-0006-4599-2404
Observed ORCID: 0009-0006-4599-2404
OpenAlex ID: A5090976014
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
2020 · Ugur Sahin, Alexander Muik, et al. · Nature · 1,973
PDF
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
2021 · Ugur Sahin, Alexander Muik, et al. · Nature · 919
PDF
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
2020 · Drew Weissman, Mohamad-Gabriel Alameh, et al. · Cell Host & Microbe · 340
PDF
A spliceosome intermediate with loosely associated tri-snRNP accumulates in the absence of Prp28 ATPase activity
2016 · Carsten Boesler, Norbert Rigo, et al. · Nature Communications · 86
PDF
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
2021 · Ugur Sahin, Alexander Muik, et al. · Nature · 33
PDF
Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al. · Molecular Cancer Therapeutics · 29
Detection of MET amplification ( MET amp) in patients with EGFR mutant (m) NSCLC after first-line (1L) osimertinib.
2023 · Helena Alexandra Yu, Keith Kerr, et al. · Journal of Clinical Oncology · 27
PDF
Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors
2024 · B. Perez, R. Aljumaily, et al. · ESMO Open · 26
Stable tri-snRNP integration is accompanied by a major structural rearrangement of the spliceosome that is dependent on Prp8 interaction with the 5′ splice site
2015 · Carsten Boesler, Norbert Rigo, et al. · RNA · 13
PDF
Sequence and Generation of Mature Ribosomal RNA Transcripts in Dictyostelium discoideum
2011 · Carsten Boesler, Janis Kruse, et al. · Journal of Biological Chemistry · 7
PDF
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
2025 · Uğur Şahin, Alexander Muik, et al. · Nature · 1
PDF
Supp. Fig. 1 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2026 · Kai Schiemann, Natalya Belousova, et al.
1O Precemtabart tocentecan (M9140): Initial results from the phase I PROCEADE-CRC-01 dose optimization study and preclinical antitumor activity across tumor models
2025 · H. Shoji, S-W. Han, et al. · ESMO Open
PDF
Supp. Fig. 2 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al.
Supp. Fig. 1 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al.
PDF
Data from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al.
Supp. Fig. 2 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al.
Supplementary Methods from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann, Natalya Belousova, et al.
Supplementary Methods from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann (20103661), Natalya Belousova (17893595), et al. · Figshare
Supp. Fig. 2 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann (20103661), Natalya Belousova (17893595), et al. · Figshare
Supp. Fig. 3 from Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo
2024 · Kai Schiemann (20103661), Natalya Belousova (17893595), et al. · Figshare
Requirements for pre-catalytic B complex formation during exon- and intron-defined spliceosome assembly
2015 · Boesler, Carsten
PDF
Works count: 22
Citation count: 3,454
H-index: 9
I10-index: 9
Year
Topic
Type